DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an ...

A pair of deals in the fourth quarter of 2024 highlights the attraction of the patient-direct market for continuous glucose ...

Given differences in socioeconomic status and higher prevalence, the Black community face disproportionate outcomes in ...

A new error grid to assess the accuracy of glucose measurements could give continuous glucose monitor manufacturers and ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the devices to help ...

SoFi Technologies (SOFI) rose for a third day on Thursday, adding 5.09 percent to close at $16.3 apiece as investors took ...

The Nix hydration monitor offers clear performance benefits and the UCI approves it for competition. Why are some sensors ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...

Intermittent fasting is an effective method for weight loss and enhances cardiovascular health in individuals with obesity. A ...

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...